AI Summary
We reviewed 30 live results for adalimumab and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologic and Biosimilar.
Comparison Table
Recommended
Adalimumab
Source: Bumrungrad International Hospital
Description
A biologic DMARD and TNF inhibitor used for patients with moderate to severe rheumatoid arthritis. Available as sterile solutions for injection (40 mg or 20 mg), it is often reserved for those who do not respond to conventional treatments.
Best for
advanced RA treatment, TNF inhibitor therapy, biologic DMARD access and patients failing conventional therapy
View Details
Rating
Yuflyma (adalimumab-aaty)
Source: Celltrion USA, Inc.
Description
Yuflyma is a high-concentration (100 mg/mL), citrate-free, and latex-free biosimilar to Humira (adalimumab), classified as a TNF blocker. It is indicated for the treatment of various inflammatory conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Available in single-dose autoinjectors and prefilled syringes at strengths like 40 mg/0.4 mL and 80 mg/0.8 mL, this biologic medication offers room-temperature stability for up to 31 days, providing flexibility for autoimmune patient care.
Best for
rheumatoid arthritis treatment, citrate-free injection preference, Humira biosimilar seekers, Crohn's disease management and flexible storage needs
View Details
Rating
Amgevita (adalimumab)
Source: Amgen Inc.
Description
Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes.
Best for
international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients
View Details
Rating
| Compare | Adalimumab | Yuflyma (adalimumab-aaty) | Amgevita (adalimumab) |
|---|---|---|---|
| Source | Bumrungrad International Hospital | Celltrion USA, Inc. | Amgen Inc. |
| Description | A biologic DMARD and TNF inhibitor used for patients with moderate to severe rheumatoid arthritis. Available as sterile solutions for injection (40 mg or 20 mg), it is often reserved for those who do not respond to conventional treatments. | Yuflyma is a high-concentration (100 mg/mL), citrate-free, and latex-free biosimilar to Humira (adalimumab), classified as a TNF blocker. It is indicated for the treatment of various inflammatory conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Available in single-dose autoinjectors and prefilled syringes at strengths like 40 mg/0.4 mL and 80 mg/0.8 mL, this biologic medication offers room-temperature stability for up to 31 days, providing flexibility for autoimmune patient care. | Amgevita is the international brand name for Amgen's adalimumab biosimilar, widely used in Canada, Europe, and New Zealand. It is indicated for the treatment of autoimmune diseases such as Hidradenitis Suppurativa, Uveitis, and juvenile idiopathic arthritis, alongside major inflammatory conditions. The product is available in convenient formats including single-use pre-filled pens and syringes. |
| Best for | advanced RA treatment, TNF inhibitor therapy, biologic DMARD access and patients failing conventional therapy | rheumatoid arthritis treatment, citrate-free injection preference, Humira biosimilar seekers, Crohn's disease management and flexible storage needs | international patients, uveitis treatment, hidradenitis suppurativa care and ankylosing spondylitis patients |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"Adalimumab from Bumrungrad International Hospital."
I picked this because A highly effective biologic option for advanced RA management available at premier private hospitals in Thailand.
Share this search
Related Finds